idarubicin has been researched along with albendazole in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ahn, KJ; Anderson, MO; Baum, J; Belanger, B; Chaplan, CA; Cheung, A; Churchyard, A; Crespo, B; DiBernardo, C; Eagon, S; Eribez, K; Falade, MO; Gamo, FJ; García-Barbazán, I; Guy, RK; Hammill, JT; Kashtanova, AS; Kim, K; Kimball, JJ; Koch, G; Laleu, B; Lazaro, H; Loop, L; Mittal, N; Rice, AL; Sigal, M; Takahashi, R; Tryhorn, JE; Wilkinson, SP; Winzeler, EA; Yniguez, K | 1 |
| DiBernardo, C; Eagon, S; Falade, MO; Fitzsimmons, K; Glidden, JE; Guy, RK; Hammill, JT; Kimball, JJ; Law, J; Manjunath, A; Nguyen, B; Rice, AL; Sienko, N; Thompson, K; Wilkinson, SP | 1 |
1 review(s) available for idarubicin and albendazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for idarubicin and albendazole
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Synthesis and Structure-Activity Relationship of Dual-Stage Antimalarial Pyrazolo[3,4-
Topics: Antimalarials; Cell Line; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Pyridines; Structure-Activity Relationship | 2020 |
Antimalarial activity of 2,6-dibenzylidenecyclohexanone derivatives.
Topics: Antimalarials; Cell Proliferation; Chloroquine; Dose-Response Relationship, Drug; Fibroblasts; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2021 |